Research in mental retardation: underreporting of medication information.
Hidden medication information still threatens behavior-analytic clarity 35 years later.
01Research in Context
What this study did
The authors read every article in six developmental-disability journals for 11 years. They counted how many papers said what drugs the participants took. Only 3 % of studies listed current meds. Only 1.5 % tested meds as part of the experiment.
What they found
Medication facts are missing from 97 % of research papers. This gap hides possible drug-behavior links. Behavior analysts cannot tell if a skill jump or problem drop came from teaching or from a new pill.
How this fits with other research
Christian et al. (1997) did the same count nine years later. Reporting rose, but still only 40 % of ID studies and 60 % of ADHD studies named meds. The trend is up, yet most drug details stay hidden.
Katz et al. (2003) stepped further. They showed that when medication studies do happen, they use weak designs. Small samples, no blinding, no behavior data. The 1988 warning about missing info became a 2003 call for better science.
Ballester et al. (2022) moved the gap from journals to clinics. They found only 64 adverse events recorded in 83 heavily medicated adults. Under-reporting is not just a paper problem; it hides harm in real time.
Why it matters
You need the full picture to plan good behavior programs. Ask families, nurses, and doctors for current med lists at intake. Note dose changes in your session log. If behavior shifts, you will know if a new pill or your teaching did the work. This simple habit protects your data and your clients.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a medication line to your intake form and update it every two weeks.
02At a glance
03Original abstract
Estimates of psychoactive drug use among persons residing in community and institutional settings suggest high prevalence rates. Psychoactive drug use has been associated with impairments in adaptive functioning. As a result, drug-induced effects may represent potential confounds that need to be considered when evaluating treatment outcomes. Consequently, information about drug regimens should be reported in empirical investigations. In this investigation, a review of six applied research and special education journals over an 11-year period was conducted to determine the extent to which information about drug regimens of participants was provided. It was determined that only slightly more than 3% of the articles reported information about subject medication usage and only 1.5% reported information relating to the use of medications as independent variables. The results are discussed in terms of their implications for recommending that providing information about drug regimens should become standard practice when describing subjects.
Research in developmental disabilities, 1988 · doi:10.1016/0891-4222(88)90030-3